Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Siyu Ding, Siyu Liu, Yaxuan Chen, Ying Peng & Jiang Zheng. (2022) Anastrozole and related glucuronic acid conjugate are electrophilic species. Xenobiotica 52:4, pages 380-388.
Read now
Read now
Adrienne E. Borrie & Richard B. Kim. (2017) Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers. Expert Opinion on Drug Metabolism & Toxicology 13:2, pages 149-156.
Read now
Read now
Xupeng Bai, Yibei Chen, Xiangyu Hou, Min Huang & Jing Jin. (2016) Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metabolism Reviews 48:4, pages 541-567.
Read now
Read now
Xiaoman Liu, Siew-Kee Low & Alan V. Boddy. (2016) The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 12:8, pages 851-863.
Read now
Read now
Douglas F. Dluzen & Philip Lazarus. (2015) MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors. Drug Metabolism Reviews 47:3, pages 320-334.
Read now
Read now
Helena Joyce, Andrew McCann, Martin Clynes & Annemarie Larkin. (2015) Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 11:5, pages 795-809.
Read now
Read now
Pilar H Saladores, Jana C Precht, Werner Schroth, Hiltrud Brauch & Matthias Schwab. (2013) Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer. Expert Review of Molecular Diagnostics 13:4, pages 349-365.
Read now
Read now
Abdullah Turkistani & Sharon Marsh. (2012) Pharmacogenomics of third-generation aromatase inhibitors. Expert Opinion on Pharmacotherapy 13:9, pages 1299-1307.
Read now
Read now
William R Miller. (2010) Aromatase inhibitors: prediction of response and nature of resistance. Expert Opinion on Pharmacotherapy 11:11, pages 1873-1887.
Read now
Read now
Articles from other publishers (22)
Yuanhuang Chen, Lauren A. Marcath, Finn Magnus Eliassen, Tone Hoel Lende, Havard Soiland, Gunnar Mellgren, Thomas Helland & Daniel Louis Hertz. (2021) Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites. Journal of Personalized Medicine 11:6, pages 507.
Crossref
Crossref
Thomas Helland, Sarah Alsomairy, Chenchia Lin, Håvard Søiland, Gunnar Mellgren & Daniel Louis Hertz. (2021) Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer. Journal of Personalized Medicine 11:3, pages 201.
Crossref
Crossref
Vikki Ho, Romain Pasquet, Shaman Luo, Gang Chen, Paul Goss, Dongsheng Tu, Philip Lazarus & Harriet Richardson. (2020) Variation in the UGT2B17 genotype, exemestane metabolism and menopause-related toxicities in the CCTG MAP.3 trial. Breast Cancer Research and Treatment 183:3, pages 705-716.
Crossref
Crossref
Kristina Bojanic, Lucija Kuna, Ines Bilic Curcic, Jasenka Wagner, Robert Smolic, Kristina Kralik, Tomislav Kizivat, Gordana Ivanac, Aleksandar Vcev, George Y. Wu & Martina Smolic. (2020) Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients’ Population. International Journal of Environmental Research and Public Health 17:10, pages 3692.
Crossref
Crossref
Yehui Zhu, Theresa A. Koleck, Catherine M. Bender & Yvette P. Conley. (2019) Genetic Underpinnings of Musculoskeletal Pain During Treatment With Aromatase Inhibitors for Breast Cancer: A Biological Pathway Analysis. Biological Research For Nursing 22:2, pages 263-276.
Crossref
Crossref
Harriet Johansson, Valentina Aristarco, Sara Gandini, Jennifer Gjerde, Debora Macis, Aliana Guerrieri-Gonzaga, Davide Serrano, Matteo Lazzeroni, Agnita Rajasekaran, Clark V Williard, Gunnar Mellgren, Andrea DeCensi & Bernardo Bonanni. (2019) Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The Pharmacogenomics Journal 20:1, pages 19-26.
Crossref
Crossref
Laith N. AL-Eitan, Doaa M. Rababa’h, Mansour A. Alghamdi & Rame H. Khasawneh. (2019) Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC Cancer 19:1.
Crossref
Crossref
Merel van Nuland, Hilde Rosing, Alwin D. R. Huitema & Jos H. Beijnen. (2019) Predictive Value of Microdose Pharmacokinetics. Clinical Pharmacokinetics 58:10, pages 1221-1236.
Crossref
Crossref
Jiangying Chen, Jialang Zhuang, Jingguo Wu, Xiaoyan Chen, Xueding Wang, Lihui Huang, Guixiong Zeng, Jie Chen, Xiaoxing Liao, Xiao Chen, Zhongfu Ma, Guoping Zhong, Min Huang, Dafang Zhong & Xianglan Zhao. (2018) Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers: A Randomized, Single‐Dose, Two‐Period, Two‐Sequence Crossover Study. Clinical Pharmacology in Drug Development 8:2, pages 217-222.
Crossref
Crossref
Murtala B. Abubakar, Huay Lin Tan, Venkata Murali Krishna Bhavaraju & Siew Hua Gan. (2019) Impact of CYP3A4 and CYP3A5 single nucleotide polymorphisms on anastrozole-associated adverse events among Malaysian breast cancer patients. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 33-42.
Crossref
Crossref
Murtala B. Abubakar, Keat Wei & Siew Hua Gan. (2014) The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients. Pharmacogenetics and Genomics 24:12, pages 575-581.
Crossref
Crossref
Aleksandra K. Greer, Centdrika R. Dates, Athena Starlard-Davenport, Vineetha K. Edavana, Stacie M. Bratton, Ishwori B. Dhakal, Moshe Finel, Susan A. Kadlubar & Anna Radominska-Pandya. (2014) A Potential Role for Human UDP-Glucuronosyltransferase 1A4 Promoter Single Nucleotide Polymorphisms in the Pharmacogenomics of Tamoxifen and Its Derivatives. Drug Metabolism and Disposition 42:9, pages 1392-1400.
Crossref
Crossref
Jana C. Precht, Werner Schroth, Kathrin Klein, Hiltrud Brauch, Evgeny Krynetskiy, Matthias Schwab & Thomas E. Mürdter. (2013) The Letrozole Phase 1 Metabolite Carbinol as a Novel Probe Drug for UGT2B7. Drug Metabolism and Disposition 41:11, pages 1906-1913.
Crossref
Crossref
Vineetha Koroth Edavana, Ishwori B. Dhakal, Suzanne Williams, Rosalind Penney, Gunnar Boysen, Aiwei Yao-Borengasser & Susan Kadlubar. (2013)
Potential Role of
UGT1A4
Promoter SNPs in Anastrozole Pharmacogenomics
. Drug Metabolism and Disposition 41:4, pages 870-877.
Crossref
Crossref
Barbara Fedejko-Kap, Stacie M. Bratton, Moshe Finel, Anna Radominska-Pandya & Zofia Mazerska. (2012) Role of Human UDP-Glucuronosyltransferases in the Biotransformation of the Triazoloacridinone and Imidazoacridinone Antitumor Agents C-1305 and C-1311: Highly Selective Substrates for UGT1A10. Drug Metabolism and Disposition 40:9, pages 1736-1743.
Crossref
Crossref
Baojian Wu, Xiaoqiang Wang, Shuxing Zhang & Ming Hu. (2012) Accurate Prediction of Glucuronidation of Structurally Diverse Phenolics by Human UGT1A9 Using Combined Experimental and In Silico Approaches. Pharmaceutical Research 29:6, pages 1544-1561.
Crossref
Crossref
Matthias Schwab, Elke Schaeffeler & Hiltrud Brauch. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
365
378
.
Jana C. Precht, Boian Ganchev, Georg Heinkele, Hiltrud Brauch, Matthias Schwab & Thomas E. Mürdter. (2012) Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS. Analytical and Bioanalytical Chemistry 403:1, pages 301-308.
Crossref
Crossref
Landry K. Kamdem, Yong Liu, Vered Stearns, Susan A. Kadlubar, Jacqueline Ramirez, Stacie Jeter, Karineh Shahverdi, Bryan A. Ward, Evan Ogburn, Mark J. Ratain, David A. Flockhart & Zeruesenay Desta. (2010) In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. British Journal of Clinical Pharmacology 70:6, pages 854-869.
Crossref
Crossref
Hiroshi Hirata, Yuji Hinoda, Mohd S. Zaman, Yi Chen, Koji Ueno, Shahana Majid, Christina Tripsas, Mary Rubin, Lee-may Chen & Rajvir Dahiya. (2010) Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancer. Carcinogenesis 31:9, pages 1620-1626.
Crossref
Crossref
Roisin Connolly & Vered Stearns. (2010) Pharmacogenetics of Aromatase Inhibitors: Present Understanding and Looking to the Future. Current Breast Cancer Reports 2:3, pages 138-145.
Crossref
Crossref
Jacqueline RamírezMark J RatainFederico Innocenti. (2010) Uridine 5´-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy. Future Oncology 6:4, pages 563-585.
Crossref
Crossref